Takeda may be paring back its R&D pipeline in the name of efficiency, but the Japanese pharma has still found $100 million to ensure its clinical pipeline once again features an Alzheimer’s disease ...
AC Immune (ACIU) announced positive interim safety and immunogenicity data from the Phase 2 VacSYn clinical trial evaluating ACI-7104.056, its wholly owned anti-alpha-synuclein active immunotherapy ...
Microchip Technology Inc. has released three scalable EV charger reference designs including a single-phase AC residential, a three-phase AC commercial with Open Charge Point Protocol (OCPP) and ...
Microchip has released three flexible and scalable EV charger reference designs for residential and commercial charging applications. These reference designs include a single-phase AC residential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results